- |||||||||| 010DS-Zn / Xylonix
[VIRTUAL] Anti-tumor effects from simultaneous cancer and TAM targeting by 010DS-Zn () - Mar 13, 2021 - Abstract #AACR2021AACR_4800;
Collectively, 010DS-Zn presents new cancer immunotherapeutic potentials for enabling previously inaccessible 2-combination therapies for targeting 3 layers of immune-evasion: Tregs, TAM, and MDSC. Furthermore, its ability to directly clear M2-like macrophages presents opportunities-worth-investigation for treating the M2-like macrophage-driven severe SARS-CoV-2 autoimmune syndromes or its post-recovery heart-damages.
|
